Gulada, Jessica .
HRN: 28-85-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
CEFUROXIME 500MG (TAB)
04/18/2026
04/25/2026
PO
1 Tab
BID
SP NSD W RMLE
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: